Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
61%
Novelty
70%
Mechanistic
Druggability
Priority
80%
Importance
65%
Tractability
80%
Market price
50%

Description

The skeptic noted AhR is promiscuous with dozens of ligands, but the mechanistic specificity of TMAO-AhR signaling remains unestablished. Understanding competitive binding and pathway selectivity is essential for therapeutic targeting.

Source: Debate session sess_SDA-2026-04-16-gap-20260416-121711_20260416-134918 (Analysis: SDA-2026-04-16-gap-20260416-121711)